Last reviewed · How we verify

NCT06220578

Analysis of Topographic Corneal Parameters

Completed Last updated 24 January 2024
What this trial tests

trial testing Oculus pentacam HR in Cornea in 2,694 participants. Completed in 31 December 2023.

Timeline
1 January 2023
Primary endpoint
30 August 2023
31 December 2023

Quick facts

Lead sponsorMinia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,694
Start date1 January 2023
Primary completion30 August 2023
Estimated completion31 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 18 to 45, any sex, with Cornea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Pentacam HR system (OCULUS) has been suggested to be one of the most sensitive instruments for corneal examination before corneal refractive surgery

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Analysis of topographic corneal parameters in a large cohort of corneal refractive surgery candidates.
    Abdelghany AA, Omar I. · · 2026 · PMID 41994243 · DOI 10.4103/sjopt.sjopt_237_24

Verify or expand the search:

Other recruiting trials for Cornea

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06220578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing